VANI Vivani Medical, Inc.
$1.27▲ +1.60%
Healthcare
Other
After hours
$1.29▲ +1.57%
Sep 11, 7:30 PM ET
Volume 249.4K
Avg Volume (10D) 266.1K
Key Metrics & Fundamentals
Market Cap
$114.56M
P/E Ratio
–
Div Yield
–%
52W Range
0.92 - 1.92
% vs 50 MA
-7.52%
% vs 200 MA
-1.00%
RSI-14
42.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.40
Free Cash Flow
-$6.13M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.75M
COGS
–
Operating Exp
$6.87M
Operating Income
-$6.87M
EBIT
-$6.87M
Pretax Income
-$6.37M
Net Income
-$6.37M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
Vivani Medical Announces Participation in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 8:08 PM
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Motley Fool · Aug 29, 2026 11:35 PM
Vivani Medical: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 8:56 PM
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 13, 2026 8:05 PM
Top Midday Gainers
MT Newswires · Aug 6, 2026 5:58 PM
Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial
MT Newswires · Aug 6, 2026 3:00 PM
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
GlobeNewswire · Aug 6, 2026 12:00 PM
Top Premarket Gainers
MT Newswires · Aug 6, 2026 11:13 AM
Vivani Medical Insider Bought Shares Worth $999,999, According to a Recent SEC Filing
MT Newswires · Jul 16, 2026 1:18 PM
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
MarketBeat · Jul 15, 2026 11:02 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See VANI's money flow as a full page
Social Sentiment
No Reddit posts found for VANI.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.